Rapid Rx Quiz: Opioids

Mary L. Windle, PharmD


July 08, 2022

Controlled-release oxycodone (OxyContin) is indicated for the management of severe pain for which alternative treatment options are inadequate in pediatric patients aged 11 years or older who are already opioid-tolerant and receiving and tolerating a minimum daily oral opioid dose of at least 20 mg oxycodone or its equivalent. The safety and efficacy of hydrocodone, tapentadol, and oxymorphone have yet to be established for pediatric patients.

Learn more about oxycodone and its dosing regimens for all patients.

This Rapid Rx Quiz was excerpted and adapted from the Medscape articles: Pain in Vain or Flexible Prescribing? CDC's Draft Opioid Guidance, Pain Management Center, Oxycodone, Cancer-Associated Pain Clinical Practice Guidelines (ASPN, 2021), AAN Updates Treatment Guidance on Painful Diabetic Neuropathy, AAOS Updates Guidelines for Nonoperative Knee OA Treatment, Opioid Analgesics, Opioid Use in Fibromyalgia Continues Despite Guidelines That Do Not Support its Efficacy or Risk, Fentanyl, and Tapentadol.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.